DEXCOM INC (DXCM)
Surgical & Medical Instruments & Apparatus · Surgical & Medical Instruments & Apparatus · NASDAQ
$89.69
-0.50%
Investru Score
64.5 / 100
Good
Why is DXCM moving?
DXCM is down 0.50% today, a pullback within its broader uptrend.
Business overview
AI explanation unavailable — the numeric report above is real; only this narrative text couldn't be generated right now.
Bull case
AI explanation unavailable — the numeric report above is real; only this narrative text couldn't be generated right now.
Bear case
AI explanation unavailable — the numeric report above is real; only this narrative text couldn't be generated right now.
DXCM’s Investru Score changed +0 points recently. Want to know exactly what changed and why? That’s a Pro feature →
Score breakdown
- Financial Quality
- 71
- Growth
- 61
- Profitability
- 62
- Balance Sheet
- 56
- Valuation
- 56
- Momentum
- 86
Score history
+0.0 over the last 3 days, driven mainly by momentum (-1).
Financial quality
AI explanation unavailable — the numeric report above is real; only this narrative text couldn't be generated right now.
- ROIC
- Data unavailable
- ROE
- 30.5%
- FCF Margin
- 23.1%
- Free Cash Flow (TTM)
- $1.1B
- Earnings Quality (OCF ÷ Net Income)
- 1.7x
Valuation
AI explanation unavailable — the numeric report above is real; only this narrative text couldn't be generated right now.
- P/E (TTM)
- 37.8x
- Forward P/E
- Data unavailable
- PEG (P/E ÷ EPS Growth)
- 0.8x
- Company Median PEG
- 0.8x
- Price / Sales
- 7.1x
- EV / EBITDA
- Data unavailable
- FCF Yield
- 3.1%
Key risks
- AI explanation unavailable — the numeric report above is real; only this narrative text couldn't be generated right now.(Probability: Medium · Impact: Medium)
Latest earnings
- Q2 FY26 EPS
- $0.64
- Estimate
- Data unavailable
- Surprise
- Data unavailable
AI explanation unavailable — the numeric report above is real; only this narrative text couldn't be generated right now.
SEC filings
- 10-Q · Q2 FY26 · period ended 2026-06-30Filed 2026-07-30
- 10-Q · Q1 FY26 · period ended 2026-03-31Filed 2026-04-30
- 10-K · FY25 · period ended 2025-12-31Filed 2026-02-12
- 10-Q · Q3 FY25 · period ended 2025-09-30Filed 2025-10-30
- 10-Q · Q2 FY25 · period ended 2025-06-30Filed 2025-07-30
- 10-K · FY24 · period ended 2024-12-31Filed 2025-02-18
- 10-K · FY23 · period ended 2023-12-31Filed 2024-02-08
- 10-K · FY22 · period ended 2022-12-31Filed 2023-02-09
- 10-K · FY21 · period ended 2021-12-31Filed 2022-02-14
Event filings (8-K) aren't covered by this page's data source yet — only 10-K/10-Q are shown above.
Market cap $34.5B · 52-week range $54.11–$92.59 · market data as of Sep 2, 2026, 4:00 PM ET · latest SEC filing: 2018-11-06
Related stocks
Get the full interactive report
Technicals, earnings history, news, bull/base/bear scenarios, Ask the Stock, and more — free to start.
Analyze DXCM with Investru AINot investment advice. Investru AI summarizes public data and AI-generated analysis for informational purposes only.